Stephen J. Clarke

Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients – analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO (2009)

Sharma, Rohini, Cunningham, David, Smith, Paul, Robertson, Graham, Dent, Owen, Clarke, Stephen J

Abstract Background Toxicity from chemotherapy is highly variable, unpredictable and results in substantial morbidity and increased healthcare costs. New predictors of toxicity are required to...

Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials (2009)

Vardy, Janette, Dadasovich, Ryan, Beale, Philip, Boyer, Michael, Clarke, Stephen J

Abstract Background Evidence that chemotherapy improves survival and quality of life in patients with stage IIIB & IV non small cell lung cancer (NSCLC) is based on large randomized controlled...

The impact of a community health advisor-based intervention on self-reported frequency of dental visits in a rural, low income African American Alabama community (2007)

Clarke, Stephen J. (Stephen John)

Thesis (Ph.D.)--University of Alabama at Birmingham, 2007.

The Development of multiple reaction monitoring assays for liver-derived plasma proteins (2007)

Mckay, Matthew J, Sherman, Jamie, Laver, Matthew T, Baker, Mark S, Clarke, Stephen J, Molloy, Mark P

There is wide interpatient variability in toxicity to chemotherapeutic drugs and a lack of routine clinical tests for prospectively identifying patients at risk of developing toxicity from...

Clinical pharmacokinetics of the irinotecan metabolite 4-piperidinopiperidine and its possible clinical importance (2000)

Dodds, Helen M., Clarke, Stephen J., Findlay, Michael, Bishop, James F., Robert, Jacques, Rivory, Laurent P.

Purpose: To investigate the clinical relevance of 4-piperidinopiperidine (4PP) in the activity of irinotecan (CPT-11), a high-performance liquid chromatography-turboionspray-tandem mass spectrometry...

Clinical pharmacokinetics of the irinotecan metabolite 4-piperidinopiperidine and its possible clinical importance (2000)

Dodds, Helen M., Clarke, Stephen J., Findlay, Michael, Bishop, James F., Robert, Jacques, Rivory, Laurent P.

Purpose: To investigate the clinical relevance of 4-piperidinopiperidine (4PP) in the activity of irinotecan (CPT-11), a high-performance liquid chromatography-turboionspray-tandem mass spectrometry...

Population pharmacokinetics of weekly docetaxel in patients with advanced cancer

Slaviero, Kellie A, Clarke, Stephen J, McLachlan, Andrew J, Blair, Elaine Y L, Rivory, Laurent P

Population pharmacokinetics of raltitrexed in patients with advanced solid tumours

Blair, Elaine Y L, Rivory, Laurent P, Clarke, Stephen J, McLachlan, Andrew J

Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients

Li, Kong M, Rivory, Laurent P, Hoskins, Janelle, Sharma, Rohini, Clarke, Stephen J

OUTLOOK FOR EMERGING TECHNOLOGIES IN SUGAR PROCESSING

Clarke, Stephen J.

Agribusiness,

Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials

Vardy, Janette, Dadasovich, Ryan, Beale, Philip, Boyer, Michael, Clarke, Stephen J

A novel approach to investigate the subcellular distribution of nuclear receptors in vivo

Matic, Marko, Nakhel, Sarah, Lehnert, Anne M., Polly, Patsie, Clarke, Stephen J., Robertson, Graham R.

Subcellular compartmentalisation and the intracellular movement of nuclear receptors are major regulatory steps in executing their transcriptional function. Though significant progress has been made...

Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients – analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO

Sharma, Rohini, Cunningham, David, Smith, Paul, Robertson, Graham, Dent, Owen, Clarke, Stephen J